AFP and hepatocellular carcinoma: While new guidance in relation to COVID-19 suggests that HCC surveillance can be deferred,6 7 it is accepted that patients with cirrhosis, elevated serum alpha-feto protein (AFP) and those with CHB among others should be prioritised.